Compounds > tocainide
Page last updated: 2024-08-23

tocainide and Muscle Contraction

tocainide has been researched along with Muscle Contraction in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camerino, DC; Corbo, F; De Luca, A; Desaphy, JF; Didonna, MP; Ferrannini, E; Franchini, C; Jockusch, H; Lentini, G; Liantonio, A; Natuzzi, F; Pierno, S; Tortorella, V1
Courtney, KR1
Conte Camerino, D; Corbo, F; De Bellis, M; De Luca, A; Desaphy, JF; Franchini, C; Jockusch, H; Lentini, G; Scilimati, A; Talon, S; Tortorella, P1
Brinkmeier, H; Jockusch, H; Mehrke, G1
Bertram, K; Füchtbauer, EM; Jockusch, H; Reininghaus, J1
Jockusch, H; Reininghaus, J; Stuhlfauth, I; Zippel, M1

Other Studies

6 other study(ies) available for tocainide and Muscle Contraction

ArticleYear
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse.
    Neuromuscular disorders : NMD, 2004, Volume: 14, Issue:7

    Topics: Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Conductivity; Electromyography; Female; In Vitro Techniques; Inhibitory Concentration 50; Male; Mexiletine; Mice; Mice, Mutant Strains; Muscle Contraction; Myotonic Disorders; Patch-Clamp Techniques; Sodium Channels; Structure-Activity Relationship; Time Factors; Tocainide

2004
Depressant effects of drugs used in myotonia therapy.
    Proceedings of the Western Pharmacology Society, 1982, Volume: 25

    Topics: Animals; In Vitro Techniques; Ion Channels; Lidocaine; Mexiletine; Muscle Contraction; Myotonia; Phenytoin; Procainamide; Quinidine; Rana catesbeiana; Tocainide

1982
Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.
    British journal of pharmacology, 2001, Volume: 134, Issue:7

    Topics: Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; In Vitro Techniques; Membrane Potentials; Mice; Mice, Mutant Strains; Muscle Contraction; Muscle, Skeletal; Mutation; Myotonia; Rana esculenta; Sodium Channel Blockers; Sodium Channels; Stereoisomerism; Structure-Activity Relationship; Tocainide

2001
The myotonic mouse mutant ADR: electrophysiology of the muscle fiber.
    Muscle & nerve, 1988, Volume: 11, Issue:5

    Topics: Action Potentials; Animals; Chlorides; Ion Channels; Lidocaine; Mice; Mice, Neurologic Mutants; Muscle Contraction; Muscles; Myotonia; Phenotype; Tocainide

1988
The myotonic mouse mutant ADR: physiological and histochemical properties of muscle.
    Muscle & nerve, 1988, Volume: 11, Issue:5

    Topics: Adenosine Triphosphatases; Animals; Electromyography; Glycerolphosphate Dehydrogenase; Lidocaine; Mice; Mice, Neurologic Mutants; Muscle Contraction; Muscles; Myotonia; Phenotype; Succinate Dehydrogenase; Tocainide

1988
Reduction of myosin-light-chain phosphorylation and of parvalbumin content in myotonic mouse muscle and its reversal by tocainide.
    European journal of biochemistry, 1988, Jan-15, Volume: 171, Issue:1-2

    Topics: Animals; Lidocaine; Mice; Mice, Mutant Strains; Muscle Contraction; Muscle Proteins; Muscles; Myosins; Myotonia; Parvalbumins; Phosphoproteins; Phosphorylation; Tocainide

1988